Cite
Halpenny M, William N, Elmoazzen H, et al. The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation. Cytotherapy. 2021;doi: 10.1016/j.jcyt.2021.09.006.
Halpenny, M., William, N., Elmoazzen, H., Giulivi, A., Martin, L., Perron, D., Bredeson, C., Hamelin, L., Huebsch, L., Yang, L., Birch, P., & Acker, J. P. (2021). The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation. Cytotherapy, . https://doi.org/10.1016/j.jcyt.2021.09.006
Halpenny, Michael, et al. "The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation." Cytotherapy vol. (2021). doi: https://doi.org/10.1016/j.jcyt.2021.09.006
Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, Bredeson C, Hamelin L, Huebsch L, Yang L, Birch P, Acker JP. The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation. Cytotherapy. 2021 Oct 20; doi: 10.1016/j.jcyt.2021.09.006. Epub 2021 Oct 20. PMID: 34688545.
Copy
Download .nbib